Manning Family Children’s makes history as Louisiana’s first Sickle Cell Disease gene therapy marking his functional cure
On Jun. 22, 2026, Louisiana’s first Sickle Cell Disease gene therapy patient is now set to pursue his…
-
-
An experimental molecule “reprograms” the brain’s defenses against Alzheimer’s disease
On Jun. 17, 2026, a team led by researcher José Vicente Sánchez Mut at the Institute for Neurosciences…
-
Biotechnology | Disease | NIH | Therapeutics
University of Oklahoma Receives $11.5 Million NIH Award to Establish Statewide Immunoengineering Research Center
On Jun. 11, 2026, the University of Oklahoma (OU) announced it had received an $11.5 million award from…
-
study finds Indoor air contains greater diversity of airborne fungi than previously thought
On Jun. 5, 2026, researchers from Imperial College London have conducted the UK’s largest-ever longitudinal study of indoor…
-
Lilly gains license for Ascidian’s gene-editing tech to develop kidney disease drugs worth up to $1.9 billion
On Jun. 3, 2026, Ascidian Therapeutics said it has signed a licensing deal for its gene-editing technology with…
-
Scientists Map Proteins From Billion-Year-Old Organism and Discover New Links to Rare Diseases
On May 27, 2026, a University of Texas at Austin-led team has identified genes by comparing groups of…
-
Abbott secures CE Mark for world’s first dual glucose-ketone sensing technology for people with diabetes
On May 27, 2026, Abbott announced it has secured CE Mark for the world’s first dual glucose‑ketone sensing…
-
Central-Eastern Europe’s oldest Neanderthal group identified by DNA taken from teeth
On May 13, 2026, DNA recovered from Neanderthal teeth found in Stajnia Cave in southern Poland shows the…
-
Penny and Phil Knight’s Gift advances research into brain resilience and aging
On May 12, 2026, Stanford University announced a $90 million gift from Penny and Philip H. Knight, MBA…
-
Thousands of previously unknown proteins discovered
On May 6, 2026, a group of international researchers announced they had discovered 1,700 new proteins. The research…
-
UVA Study Reveals How New Weight-Loss Drugs Reshape the Brain
On May 6, 2026, In a study published in Nature, a team led by University of Virginia (UVA)…
-
USC launches transformational AI initiative with $200 million gift
On May 5, 2026, the University of Southern California (USC) announced a transformational initiative that will leverage AI…
-
Canada approves second generic semaglutide, the first G7 country to do so
On May 1, 2026, Health Canada authorized a second generic semaglutide injection. Health Canada is currently reviewing seven other…
-
Researchers create groundbreaking first-draft map of genetic interactions within human cells
On Apr. 30, 2026, researchers at the University of Bonn and University Hospital Bonn have created a groundbreaking…
-
Artificial Intelligence | Biotechnology | Diagnostics | Disease | Genomics | Neurology | Non-Profit Research | Oncology | Therapeutics
Biohub Launches the Virtual Biology Initiative to Galvanize a Global Effort to Create the Open Data Foundation for AI-Accelerated Biolog
On Apr. 29, 2026, Biohub announced the Virtual Biology Initiative, a landmark five-year initiative to galvanize a global…
-
Scientists Create First-Ever ‘Smell Map’
On Apr. 28, 2026, scientists Sandeep (Robert) Datta, professor of neurobiology in the Blavatnik Institute at Harvard Medical…
-
Girl’s sight restored after ‘life-changing’ gene therapy
On Apr. 23, 2026, a research team at the University College London (UCL) and Great Ormond Street Hospital…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss
On Apr. 23, 2026, the U.S. Food and Drug Administration (FDA) approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual…
-
Kailera nets $625M, biotech’s biggest-ever IPO
On Apr. 17, 2026, Kailera Therapeutics, a high-profile drug startup aiming to compete with Novo Nordisk and Eli…
-
Biotechnology | Diagnostics | Disease | Genomics | Oncology | Therapeutics
Roche Expands Foundation Medicine With Acquisition of SAGA Diagnostics’ Tumor-Informed Molecular Residual Disease Platform for $595 million
On Apr. 15, 2026, Foundation Medicine, an independent affiliate of the Roche group, announced it is set to…
-
Scientists reverse brain aging, with a nasal spray
On Apr. 14, 2026, a landmark study from researchers at the Texas A&M University Naresh K. Vashisht College…
-
Novo Nordisk partners with OpenAI in weight loss drug race
On Apr. 14, 2026, Novo Nordisk, the maker of popular weight-loss drugs Ozempic and Wegovy, is partnering with OpenAI…
-
Hidden mutations in immune cells linked to autoimmune disease
On Apr. 14, 2026, researchers from the Wellcome Sanger Institute, Cambridge University Hospitals NHS Foundation Trust (CUH), the…
-
Autoimmune diseases share genetic patterns
On Apr. 9, 2026, researchers from Karolinska Institutet and collaborating institutions report that different autoimmune diseases often share…
-
Biotechnology | Disease | FDA | Therapeutics
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
On Mar. 30, 2026, Biogen announced that the High Dose Regimen of SPINRAZA® (nusinersen), which is comprised of…
-
Implantable ‘Living Pharmacy’ Produces Multiple Drugs Inside the Body
On Mar. 27, 2026, A multi-institutional team of scientists, co-led by Northwestern University, has taken a crucial step…
-
Biotechnology | Disease | FDA | Pharmaceutical | Rare Disease | Stem Cell
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
On Mar. 27, 2026, Rocket Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has granted accelerated approval…
-
Biotechnology | Disease | Neurology | Oncology | Pharmaceutical | Quantum
Merck to Acquire Terns Pharmaceuticals for $5.7 Billion, Expanding Its Hematology Pipeline With TERN-701, a Novel Candidate for Chronic Myeloid Leukemia
On Mar. 25, 2026, Merck, and Terns Pharmaceuticals, a clinical-stage oncology company, announced that the companies have entered…
-
New enzyme atlas rewrites decades of biology research
On Mar. 23, 2026, The Walter and Eliza Hall Institute of Medical Research (WEHI) researchers have led a…
-
An analysis of 2.2 million people reveals shared and substance-specific genetic pathways for addiction risk
On Mar. 20, 2026, researchers of a Rutgers Health–led study led by Holly Poore, a faculty instructor of psychiatry…
